Trial Details
NOT_YET_RECRUITINGBasic Information
| Clinical ID | c114 |
|---|---|
| Identifier | NCT07161297 |
| Trial Title | Remimazolam for Colonoscopy in IBD Patients |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | IBD (Inflammatory Bowel Disease) |
| Interventions | DRUG: Intravenous remimazolam (5 mg initially, with optional 2.5 mg boluses) plus fentanyl (100 mcg) for procedural sedation.|DRUG: Intravenous midazolam (3 mg initially, with optional 3 mg boluses) plus fentanyl (100 mcg) for procedural sedation. |
Participant Information
| Sponsor | Humanitas Clinical and Research Center |
|---|---|
| City | Rozzano |
| Country/Region | Italy |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2025-09-01 |
|---|---|
| Primary Completion Date | 2025-09-07 |
| Completion Date | 2025-09-30 |